Fournier’s gangrene: a clinical profile of 30 cases

Authors

  • Kavya T. Department of General Surgery, Bangalore Medical college and Research Institute, Bengaluru, Karnataka, India
  • Rajashekara Babu G. Department of General Surgery, Bangalore Medical college and Research Institute, Bengaluru, Karnataka, India
  • Santhosh C. S. Department of General Surgery, Bangalore Medical college and Research Institute, Bengaluru, Karnataka, India

DOI:

https://doi.org/10.18203/2349-2902.isj20180831

Keywords:

Debridement, Fournier’s gangrene, Hyperleukocytosis, Polymicrobial

Abstract

Background: Fournier's gangrene is a rapidly progressive synergistic infection involving the perineal region and the scrotum and/or the penis. This study was conducted to know about the etiology and mode of presentation of Fournier’s gangrene and the impact of early and aggressive multimodality treatment in reduction in morbidity and mortality associated with this condition which is still considered to be significantly high.

Methods: The medical records of 30 patients of Fournier's gangrene who presented to the hospital between May 2014 to June 2017 were retrospectively reviewed to analyze the presentation, progression and the outcome of the disease.

Results: The study included a total of 30 male patients. The mean age was 57 years (range 38-72 years). The most common etiology was secondary to anorectal pathology (40%). The most common predisposing factor was noticed to be diabetes mellitus (73.34%). Pain and tenderness in the perineal region was present in most of the patients and scrotal involvement was seen in 66.67% of the patients. Fever was the most common prodromal condition seen in 93.33% all of which in turn were associated with tachycardia. Hyperleukocytosis was seen in 93.33% of patients except for one patient who was diagnosed to be retropositive on admission. The microbiological profile yielded polymicrobial culture report in 80% of the patients and monomicrobial in the rest with Escherichia coli being the most common organism isolated from 80% of the patients. All patients underwent adequate resuscitation, primary emergency debridement with parenteral antibiotic therapy. All the patients recovered after a mean hospital stay of 16.93 days (range 9-30 days). The mortality rate in present study was found to be 6.67%.

Conclusions: In spite of the advancements in the field of medicine Fournier’s gangrene still remains a disease with questionable degree of morbidity and mortality and early detection and treatment with aggressive debridement seems to be the only way of obtaining a good prognosis in these patients.

References

Smith GL, Bunker CB, Dinneen MD. Fournier's gangrene. Br J Urol. 1998 Mar 1;81:347-55.

Fustes-Morales A, Gutierrez-Castrellon P, Duran-Mckinster C, Orozco-Covarrubias L, Tamayo-Sanchez L, Ruiz-Maldonado R. Necrotizing FasciitisReport of 39 Pediatric Cases. Arch Dermatol. 2002;138(7):893-9.

Eke N. Fournier's gangrene: a review of 1726 cases. Br J Surg. 2000;87:718-28.

Nathan B. Fournier’s gangrene: a historical vignette. Canadian J Surg. 1998;41(1):72.

Fournier JA. Jean-Alfred Fournier 1832-1914. Gangrene foudroyante de la verge (overwhelming gangrene). Sem Med 1883. Dis Colon Rectum. 1988;31:984-8.

Gray JA. Gangrene of the genitalia as seen in advanced periurethral extravasation with phlegmon. J Urol. 1960;84(6):740-5.

Pawłowski W, Wroński M, Krasnodȩbski IW. Fournier's gangrene. Polski Merkuriusz Lekarski. 2004;16(97):85-7.

Morpurgo E, Galandiuk S. Fournier's gangrene. Surgical Clinics of North America. 2002 Dec 1;82(6):1213-24.

Clayton MD, Fowler JJ, Sharifi RO, Pearl RK. Causes, presentation and survival of fifty-seven patients with necrotizing fasciitis of the male genitalia. Surgery, Gynecology obstetrics. 1990 Jan;170(1):49-55.

Elem B, Ranjan P. Impact of immunodeficiency virus (HIV) on Fournier's gangrene: observations in Zambia. Annals of the Royal College of Surgeons of England. 1995 Jul;77(4):283.

Ersay A, Yilmaz G, Akgun Y, Celik Y. Factors affecting mortality of Fournier’s gangrene: review of 70 patients. ANZ Journal of Surgery. 2007 Jan 1;77(1‐2):43-8.

Paty R, Smith AD. Gangrene and Fournier's gangrene. The Urologic clinics of North America. 1992 Feb;19(1):149-62.

Morua AG, Lopez JA, Garcia JD, Montelongo RM, Guerra LS. Fournier’s gangrene: our experience In 5 Years, bibliographic review and assessment of the Fournier’s gangrene severity index. Arch Esp Urol. 2009;8:532–540.

Chawla SN, Gallop C, Mydlo JH. Fournier’s gangrene: an analysis of repeated surgical debridement. European urology. 2003;43(5):572-5.

Ozturk E, Ozguc H, Yilmazlar T. The use of vacuum assisted closure therapy in the management of Fournier's gangrene. The American Journal of Surgery. 2009 May 1;197(5):660-5.

Assenza M, Cozza V, Sacco E. VAC (Vacuum Assisted Closure) treatment in Fournier's gangrene: personal experience and literature review. La Clinica Terapeutica. 2011;162(1):e1-5.

Downloads

Published

2018-02-26

Issue

Section

Original Research Articles